Recombinant allergens: the present and the future - Wikidata - awgldk - TriplyDB

Recombinant allergens: the present and the future

Recombinant allergens: the present and the future

http://www.wikidata.org/entity/Q26996701

about

Allergen Immunotherapy: Past, Present, and Future Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy Molecular biomarkers for grass pollen immunotherapy.Cloning, expression, and analysis of a cDNA coding for the Dermatophagoides farinae group 21 (Der f 21) allergen.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).Allergen-Specific Immunotherapy in Asthma.Hypoallergenic molecules for subcutaneous immunotherapy.

P2860

Q26765974-6B4388B5-9661-468D-9850-9F768162C8C8 Q26852113-274C053A-9F21-4025-B3D3-4DBF9B5B64D6 Q34093047-29E30277-29FF-44C6-9A2F-DE403E246212 Q34978803-FC9512AA-662A-46B7-A27D-00BCF3D71025 Q35777126-2417FB95-7F03-4B97-86C5-3E0B37AD0D6E Q37652965-86B0D5F4-6990-4D29-A21E-F649F9D904EC Q42587580-49B6B8E7-1347-46A9-9F01-DE82D8BB13DD Q52838536-34D9D989-A218-4985-97D5-7721B71382BE

P2860

Recombinant allergens: the present and the future

http://www.wikidata.org/entity/Q26996701

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Recombinant allergens: the present and the future

@ast

Recombinant allergens: the present and the future

@en

Recombinant allergens: the present and the future

@nl

type

label

Recombinant allergens: the present and the future

@ast

Recombinant allergens: the present and the future

@en

Recombinant allergens: the present and the future

@nl

prefLabel

Recombinant allergens: the present and the future

@ast

Recombinant allergens: the present and the future

@en

Recombinant allergens: the present and the future

@nl

P1433

Q26996701-2D9B1695-8F16-4117-87B3-58380AFEA46F

P1476

Q26996701-4471E439-A80E-475F-B0BB-8C378264AE7E

P2093

Q26996701-C4CFBE48-3EA0-4BF2-BB5A-0AD6CC08FA64

Q26996701-CBC3CFEA-E028-4EC0-B7A6-0F474616830D

P2860

Q26996701-029C8C96-814E-4A09-8BCE-E41F150ADC49

Q26996701-0A31ACD5-5DA5-42BC-8B42-3CA7C996B4B1

Q26996701-0C0B7968-FF08-4E97-8605-421B0E6FC3DC

Q26996701-0C45A0BD-F60A-45F3-8692-B9E337B7EDC6

Q26996701-112E765F-DC05-47BD-A1D4-293C066C4D10

Q26996701-13C09B57-FDF0-4D23-8AC5-563C832D1D3F

Q26996701-140C89C9-68B7-4926-9BEE-D822F4B5A767

Q26996701-14A7BD38-60D9-402F-9CCF-9C67948E4D29

Q26996701-192ACB62-6BAD-4188-B5BC-5DAF27ED8D43

Q26996701-1CEDC1B2-4B9A-42EA-8079-16617AC11FAD

P304

Q26996701-A959605C-4AC8-42EF-8966-6CD7CB86FA92

P31

Q26996701-2AC67177-29EE-43DE-8050-B02E8E6000A3

P3181

Q26996701-33A1626C-AEE8-4A51-ACD4-88A4E5FB3948

P356

Q26996701-67C2C0E8-5E50-4876-B361-821676FD8F4E

P407

Q26996701-4773C4E6-4FA2-4894-A073-9D075560A58D

P433

Q26996701-9694B265-DA99-48BD-9E66-0B93A8AC1DA6

P478

Q26996701-35EE699A-683B-4490-B5D7-54BC6968734B

P50

Q26996701-33D73EB1-EF84-4076-84D8-6903C2176836

P577

Q26996701-B24D4AB5-38A0-4308-A0ED-F1D42463EA81

P5875

Q26996701-3404B1D6-6274-4FA8-883F-BD7ED98304DD

P698

Q26996701-277CB35C-E912-4A2D-8A68-DCDB1EA2D572

P932

Q26996701-E36A7ED9-8310-4517-844E-18AE84C2937A

P3181

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Recombinant allergens: the present and the future

@en

P2093

Katarzyna Solarewicz-Madejek

http://www.w3.org/2001/XMLSchema#string

Sylwia Smolinska

http://www.w3.org/2001/XMLSchema#string

P2860

Yeast RNA polymerase II genes: isolation with antibody probes

Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy.

Identification, characterization, and cloning of a complementary DNA encoding a 60-kd house dust mite allergen (Der f 18) for human beings and dogs.

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

IgE-binding epitopes: a reappraisal.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

House dust mite allergens in asthma and allergy.

Allergen cross-reactivity between house-dust mites and other invertebrates.

Characterization and immunobiology of house dust mite allergens.

Latex-fruit syndrome.

P304

1534-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1961086

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/HV.22064

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232699271

http://www.w3.org/2001/XMLSchema#string

P698

23095874

http://www.w3.org/2001/XMLSchema#string

P932

3660775

http://www.w3.org/2001/XMLSchema#string